Veröffentlichungen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Akalin, Altuna Dr. (1) Berruezo Llacuna, Maria (1) Beule, Dieter Dr. (1) Blankenstein, Thomas Prof. Dr. (1) Blüthgen, Nils (1) Caganova, Marieta Dr. (1) Daniel, Peter Prof. Dr. (1) Di Virgilio, Michela Prof. Dr. (1) Driesner, Madlen (1) Graf, Robin Dr. (2) Höpken, Uta Elisabeth PD Dr. (1) Kammertöns, Thomas Dr. (1) Keller, Lisa (1) Keller, Ulrich Dr. med. (2) Kieback, Elisa Dr. (1) Kobelt, Dennis Dr. (1) Kocks, Christine Dr. (1) Leutz, Achim Prof. Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (6) Mertins, Philipp Dr. (1) Popp, Oliver Dr. (1) Prigione, Alessandro Prof. Dr. (1) Rahjouei, Ali Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Rehm, Armin Dr. (1) Uckert, Wolfgang Prof. Dr. (4) (-) Janz, Martin Dr. (8) (-) Leisegang, Matthias Dr. (1) (-) Wollert-Wulf, Brigitte (2) Bioinformatics (1) (-) Biologie maligner Lymphome (8) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Genomdiversifikation & Integrität (1) Mikroumgebung als Regulator bei Autoimmunität und Krebs (1) Molekulare Immunologie und Gentherapie (2) (-) Molekulare Zellbiologie und Gentherapie (2) Proteom Dynamik (8) Proteomforschung und molekulare Mechanismen bei neurodegenerativen Erkrankungen (1) RNA Biologie und Posttranscriptionale Regulation (1) Translationale Tumorimmunologie (1) Zelldifferenzierung und Tumorigenese (1) 2003 (3) 2004 (2) 2005 (2) (-) 2006 (5) 2007 (2) 2008 (3) 2009 (3) 2010 (5) 2011 (5) 2012 (5) 2013 (2) 2014 (2) 2015 (5) 2016 (3) 2017 (5) 2018 (1) 2019 (1) (-) 2020 (4) 2021 (3) 2022 (6) 2023 (1) 9 Ergebnisse: Active Filter: Janz, Martin Dr.Leisegang, Matthias Dr.Wollert-Wulf, BrigitteBiologie maligner LymphomeMolekulare Zellbiologie und Gentherapie20062020 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 20. Oktober 2020 / Proc Natl Acad Sci U S A The transcription factor C/EBPβ orchestrates dendritic cell maturation and functionality under homeostatic and malignant conditions F. Scholz M. Grau L. Menzel A. Graband M. Zapukhlyak A. Leutz M. Janz G. Lenz A. Rehm U.E. Höpken 05. Oktober 2020 / J Exp Med PDGFA-associated protein 1 protects mature B lymphocytes from stress-induced cell death and promotes antibody gene diversification V. Delgado-Benito M. Berruezo-Llacuna R. Altwasser W. Winkler D. Sundaravinayagam S. Balasubramanian M. Caganova R. Graf A. Rahjouei M.T. Henke M. Driesner L. Keller A. Prigione M. Janz A. Akalin M. Di Virgilio 01. Oktober 2020 / Invest New Drugs Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma F. Kroschinsky J.M. Middeke M. Janz G. Lenz M. Witzens-Harig R. Bouabdallah P. La Rosée A. Viardot G. Salles S.J. Kim T.M. Kim O. Ottmann J. Chromik A.M. Quinson U. von Wangenheim U. Burkard A. Berk N. Schmitz 06. Juli 2020 / J Exp Med Restriction of memory B cell differentiation at the germinal center B cell positive selection stage A. Toboso-Navasa A. Gunawan G. Morlino R. Nakagawa A. Taddei D. Damry Y. Patel P. Chakravarty M. Janz G. Kassiotis R. Brink M. Eilers D.P. Calado 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
20. Oktober 2020 / Proc Natl Acad Sci U S A The transcription factor C/EBPβ orchestrates dendritic cell maturation and functionality under homeostatic and malignant conditions F. Scholz M. Grau L. Menzel A. Graband M. Zapukhlyak A. Leutz M. Janz G. Lenz A. Rehm U.E. Höpken
05. Oktober 2020 / J Exp Med PDGFA-associated protein 1 protects mature B lymphocytes from stress-induced cell death and promotes antibody gene diversification V. Delgado-Benito M. Berruezo-Llacuna R. Altwasser W. Winkler D. Sundaravinayagam S. Balasubramanian M. Caganova R. Graf A. Rahjouei M.T. Henke M. Driesner L. Keller A. Prigione M. Janz A. Akalin M. Di Virgilio
01. Oktober 2020 / Invest New Drugs Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma F. Kroschinsky J.M. Middeke M. Janz G. Lenz M. Witzens-Harig R. Bouabdallah P. La Rosée A. Viardot G. Salles S.J. Kim T.M. Kim O. Ottmann J. Chromik A.M. Quinson U. von Wangenheim U. Burkard A. Berk N. Schmitz
06. Juli 2020 / J Exp Med Restriction of memory B cell differentiation at the germinal center B cell positive selection stage A. Toboso-Navasa A. Gunawan G. Morlino R. Nakagawa A. Taddei D. Damry Y. Patel P. Chakravarty M. Janz G. Kassiotis R. Brink M. Eilers D.P. Calado
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken